MusclePharm to Report 2014 Second Quarter Financial Results

Marketwired

DENVER, CO--(Marketwired - Jul 29, 2014) - MusclePharm Corporation (OTCQB: MSLP), a scientifically-driven, performance-lifestyle sports nutrition company, will report its financial results for the second quarter ended June 30, 2014 on Monday, August 4, 2014, after market close.

The Company will conduct a conference call the following day on Tuesday, August 5, 2014 at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time.

2014 Second Quarter Conference Call Information

When:
Tuesday, August 5

Time:
8:30 a.m. Eastern Time

Phone:
1-877-407-9126 (domestic)
1-201-493-6751 (international)

A live webcast will be available online on MusclePharm's website at http://ir.musclepharmcorp.com, where it will be archived for one year.

An audio replay of the conference call will be available through midnight August 12 by dialing 877-407-9126 from the U.S. or Canada, or 201-612-7415 from international locations, passcode 13581597.

About MusclePharm

MusclePharm® is a scientifically-driven, performance lifestyle company that currently develops, manufactures, markets and distributes branded nutritional supplements. The company offers a complete range of powders, capsules, tablets and gels. Its portfolio of recognized brands, including MusclePharm® Hybrid and Core Series, Arnold Schwarzenegger Series™ and FitMiss™, are marketed and sold in more than 110 countries and available in over 35,000 retail outlets globally. These clinically-proven and scientific nutritional supplements are developed through a six-stage research process utilizing the expertise of leading nutritional scientists, doctors and universities. MusclePharm is the innovator of the sports nutrition industry. For more information, visit www.musclepharm.com.

Follow the company at http://www.facebook.com/MusclePharm and www.Twitter.com/MusclePharm

To sign up to receive MusclePharm news via email, please visit http://ir.musclepharmcorp.com/email-alerts

Contact:

Matt Sheldon/Evan Pondel
PondelWilkinson Inc.
(310) 279-5980
investors@musclepharm.com
View Comments (0)